CORCEPT THERAPEUTICS INC Increase (Decrease) in Accrued Liabilities
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Accrued Liabilities of $255.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2014-03-14
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for the quarter ending 2013-12-31 was $14.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for the quarter ending 2013-09-30 was -$28.00K, a 115.30% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for the quarter ending 2013-06-30 was -$106.00K, a 150.48% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for the quarter ending 2013-03-31 was $375.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for fiscal 2013 was $255.00K, a 7.27% decline from fiscal 2012.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for fiscal 2012 was $275.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for fiscal 2011 was -$1.46M, a 1474.53% decline from fiscal 2010.
- CORCEPT THERAPEUTICS INC increase (decrease) in accrued liabilities for fiscal 2010 was $106.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accrued Liabilities 158 month | Increase (Decrease) in Accrued Liabilities 161 month | Increase (Decrease) in Accrued Liabilities 164 month | Increase (Decrease) in Accrued Liabilities 167 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$14.00K derived: sum of 2 quarters · filed 2014-03-14 | -$120.00K derived: sum of 3 quarters · filed 2014-03-14 | $255.00K 10-K · filed 2014-03-14 | ||||||||
| 2013-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$134.00K derived: sum of 2 quarters · filed 2013-11-12 | $241.00K 10-Q · filed 2013-11-12 | $189.00K derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2013-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $269.00K 10-Q · filed 2013-08-09 | $217.00K derived: sum of 3 quarters · filed 2014-03-14 | $400.00K derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2013-03-31 | $375.00K 10-Q · filed 2013-05-08 | $323.00K derived: sum of 2 quarters · filed 2014-03-14 | $506.00K derived: sum of 3 quarters · filed 2014-03-14 | $716.00K derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2012-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $131.00K derived: sum of 2 quarters · filed 2014-03-14 | $341.00K derived: sum of 3 quarters · filed 2014-03-14 | $275.00K 10-K · filed 2014-03-14 | $199.00K 10-K · filed 2013-03-15 | |||||||
| 2012-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $393.00K derived: sum of 2 quarters · filed 2013-11-12 | $327.00K 10-Q · filed 2013-11-12 | -$39.00K 10-Q · filed 2012-11-08 | -$1.07M derived: sum of 4 quarters · filed 2014-03-14 | |||||||
| 2012-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $144.00K 10-Q · filed 2013-08-09 | -$4.00K 10-Q · filed 2012-08-09 | -$1.25M derived: sum of 3 quarters · filed 2014-03-14 | -$1.30M derived: sum of 4 quarters · filed 2014-03-14 | |||||||
| 2012-03-31 | -$66.00K 10-Q · filed 2013-05-08 | $137.00K 10-Q · filed 2012-05-10 | -$1.46M derived: sum of 2 quarters · filed 2014-03-14 | -$1.51M derived: sum of 3 quarters · filed 2014-03-14 | -$1.40M derived: sum of 4 quarters · filed 2014-03-14 | $781.00K 10-Q · filed 2012-05-10 | ||||||
| 2011-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$1.44M derived: sum of 2 quarters · filed 2014-03-14 | -$1.34M derived: sum of 3 quarters · filed 2014-03-14 | -$1.46M 10-K · filed 2014-03-14 | -$171.00K 10-K · filed 2012-03-13 | $644.00K 10-K · filed 2012-03-13 | ||||||
| 2011-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $61.00K derived: sum of 2 quarters · filed 2012-11-08 | -$60.00K 10-Q · filed 2012-11-08 | -$96.00K derived: sum of 4 quarters · filed 2013-03-15 | $755.00K 10-Q · filed 2011-11-08 | |||||||
| 2011-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$16.00K 10-Q · filed 2012-08-09 | -$52.00K derived: sum of 3 quarters · filed 2013-03-15 | -$324.00K derived: sum of 4 quarters · filed 2013-03-15 | $799.00K 10-Q · filed 2011-08-09 | |||||||
| 2011-03-31 | -$121.00K 10-Q · filed 2012-05-10 | -$157.00K derived: sum of 2 quarters · filed 2013-03-15 | -$429.00K derived: sum of 3 quarters · filed 2013-03-15 | |||||||||
| 2010-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$308.00K derived: sum of 2 quarters · filed 2013-03-15 | $106.00K 10-K · filed 2013-03-15 | |||||||||
| 2010-09-30 | -$272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $142.00K 10-Q · filed 2011-11-08 | ||||||||||
| 2010-06-30 | $414.00K 10-Q · filed 2011-08-09 | |||||||||||
| 2009-12-31 | -$280.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |